Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00032695 · ClinicalTrials.gov registry record · Phase 3
Treatment of AIDS Vacuolar Myelopathy With Methionine
A Phase 3 study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Completed
- Registry status
- Phase 3
- Development phase
- 56
- Enrollment target
NCT00032695 is a Phase 3 study that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 56 participants.
The verdict
NCT00032695, a Phase 3 study, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 56 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether methionine, an amino acid present in low doses in the normal diet, can improve myelopathy or stop its progression.
Interventions
- DRUG methionine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00032695
The ClinicalTrials.gov registry entry for NCT00032695 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which methionine is the first listed.
NCT00032695 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00032695 about?
NCT00032695 is a clinical study titled "Treatment of AIDS Vacuolar Myelopathy With Methionine". The purpose of this study is to determine whether methionine, an amino acid present in low doses in the normal diet, can improve myelopathy or stop its progression.
What is the current status of trial NCT00032695?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 56 participants.
What interventions are being tested in trial NCT00032695?
The interventions under investigation include: methionine (DRUG).
Who is sponsoring clinical trial NCT00032695?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.